What is mTilda?
Founded in 2000 and headquartered in Houston, Texas, mTilda operates as a specialized software provider for HLA laboratories. The company's flagship Information Management System is engineered to address the unique requirements of histocompatibility and immunogenetics, offering a comprehensive suite of modules that manage specimen workflows, patient data, inventory control, and reagent vendor connectivity. By facilitating seamless interoperability with institutional Electronic Medical Records (EMR) and Laboratory Information Systems (LIS), mTilda enables clinical facilities to optimize their operational efficiency and ensure high-fidelity reporting. The platform is designed to support the rigorous demands of transplant centers and immunology labs, positioning the firm as a foundational technology partner in the clinical diagnostics ecosystem.
How much funding has mTilda raised?
mTilda has raised a total of $750K across 1 funding round:
Other Financing Round
$750K
Other Financing Round (2021): $750K with participation from Golden Section Venture Capital
Key Investors in mTilda
Golden Section Venture Capital
Golden Section Technology Venture Capital is a global investment firm that partners with driven entrepreneurs to build and scale high-impact technology companies.
What's next for mTilda?
With this major enterprise-level funding, mTilda is well-positioned to accelerate its product development roadmap and expand its footprint within the global clinical laboratory market. The strategic allocation of this capital will likely focus on enhancing the interoperability features of its platform, ensuring that the system remains compatible with evolving EMR standards and complex regulatory requirements. Furthermore, the company is expected to leverage this financial momentum to scale its customer support infrastructure and deepen its integration capabilities, thereby solidifying its competitive advantage. As the industry moves toward more integrated, data-driven diagnostic workflows, mTilda's focus on specialized HLA management software provides a clear pathway for sustained growth and long-term value creation for its institutional partners.
See full mTilda company page
